SUMMARY At a certain level of stimulation of the enzymatic secretions of the pancreas utilizing duodenal hormones and caerulein in normal subjects, the hourly urinary amylase output increases beyond normal values. Under these conditions, the so-called evocative pancreatic function test becomes unusable for the diagnosis of chronic pancreatitis in the early stages.
The clinical exploration of the pancreas by the duodenal hormones-secretin and pancreozymindoes not consist only in the measurement of the functional capacity of the gland in the juice collected by duodenal intubation but it is possible to combine this with measuring the enzyme activity in the blood by the evocative pancreatic function test. Burton, Hammond, Harper, Howat, Scott, and Varley (1960) have shown that while in normal subjects the administration of submaximal doses of these duodenal hormones does not modify the blood amylase and lipase levels, in cases of pancreatitis these levels increase as long as the lesions of the gland are not too severe. In previous studies (Delcourt and Wettendorff, 1964; Wettendorff, Hensgens van der Hoeden, and Delcourt, 1970) it has been demonstrated that from this point of view the hourly measurement of the urinary amylase output is more sensitive than that of the blood amylase level. In six cases of pancreatitis, the urinary amylase output was markedly increased while the composition of the pancreatic juice collected during a duodenal intubation after hormonal stimulation was normal in four cases and only moderately deficient in two. The stimulation of the pancreas was produced by half-hourly intravenous injections of secretin followed by 15 U/kg pancreozymin (Boots). Recently we modified our protocol for pancreatic investigation, by the use of a more powerful preparation of secretin (GIH) and by a double stimulation of pancreatic enzyme secretion with caerulein (Farmitalia) and CCK (GIH). Under these conditions we observed in certain normal subjects an increase in urinary amylase output greatly exceeding the values previously considered as the upper limits of normal.
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Material and Methods
Duodenal intubation was carried out using a technique previously described by van der Hoeden et al (1971) . Secretin (GIH) was injected by the intravenous route at a dose of 1 U/kg at the same time as caerulein (Farmitalia) at a dose of 40 ng/kg. As we have shown in a recent study (Fox, van der Hoeden, and Delcourt, 1971) , the latter substance has the same physiological action on the enzymatic secretion of the pancreas and on the biliary tract as that of pancreozymin with the advantage that it is pure. At a dose of 40 ng/kg, the activity is comparable to that of pancreozymin (Boots) at a dose of 1.5 U/kg. After injection, the biliary-pancreatic secretions were continuously aspirated for 30 minutes and divided into three 10-minute samples. With The average and extreme values for the four parameters studied on the six 10-minute samples were: volume, 290 ml (177-413); maximum concentration of bicarbonate, 93 m-equiv/l (68-120); bicarbonate output, 21V3 m-equiv (13.4-31.6); and amylase output, 245 000 VLU (14Z000415 000). Except for the maximum concentration of bicarbonate, which did not change, these values are markedly greater than those we had obtained using Boots secretin (1.5 U/kg) and pancreozymin (1.5 U/kg) or caerulein (Farmitalia) (40 ng/kg) (Fox et al, 1971; van der Hoeden et al, 1971) . Table I shows the results obtained with the two types of stimulation.
HOURLY URINARY AMYLASE OUTPUT Although, after stimulation using pancreozymin (Boots) or caerulein at the doses mentioned above, we observed no modification in the hourly urinary amylase output in normal subjects we noted a marked increase after stimulation using caerulein-cecekin (GIH). study, we had considered 300 Units as the upper limit of normal. If we now consider the maximum outputs in each of the 12 cases studied, we notice that the value of 300 U/hr is only exceeded in six of these (fig 1) . If we examine the pancreatic amylase output in the duodenal juice, we notice that the same six patients also secreted a great deal more enzyme than the six others. Figure 2 shows the profile of urinary amylase output during the test. Two groups of subjects are separated. The first group (A), in which the amylase output in urine does not increase above normal, and in duodenal juice is distinctly less important than in the other group (B), in which abnormal values for urinary amylase output are demonstrated after stimulation of the pancreas. The level of amylase output in duodenal juice above which an increase of amylase output in urine may appear lies at about 180000 VLU/hour. We had previously observed this abnormality during continuous perfusions of secretin, when a strong stimulation of pancreatic enzymes was produced by giving increasing isolated doses of caerulein with the purpose of studying the action of this polypeptide on the normal pancreas. 
Discussion
The evocative pancreatic function test based on a modification of the hourly urinary amylase output as described previously (Wettendorff et al, 1970) implied that there was no increase in this value in normal subjects. 
